Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection

Jeffrey M. Jacobson, John Spritzler, Lawrence Fox, John L. Fahey, J. Brooks Jackson, Miriam Chernoff, David A. Wohl, Albert W. Wu, Thomas M. Hooton, Beverly E. Sha, Cecilia M. Shikuma, Laurie A. MacPhail, David M. Simpson, Carol B. Trapnell, Nesli Basgoz

Research output: Contribution to journalArticle

80 Scopus citations

Abstract

A multicenter, double-blind, randomized, placebo-controlled clinical trial was conducted to determine the safety and efficacy of thalidomide for treating esophageal aphthous ulceration in persons infected with human immunodeficiency virus (HIV). Twenty-four HIV-infected patients with biopsy- confirmed aphthous ulceration of the esophagus were randomly assigned to receive either oral thalidomide, 200 mg/day, or oral placebo daily for 4 weeks. Eight (73%) of 11 patients randomized to receive thalidomide had complete healing of aphthous ulcers at the 4-week endoscopic evaluation, compared with 3 (23%) of 13 placebo-randomized patients (odds ratio, 13.82; 95% confidence interval, 1.16-823.75; P = .033). Odynophagia and impaired eating ability caused by esophageal aphthae were improved markedly by thalidomide treatment. Adverse events among patients receiving thalidomide included somnolence (4 patients), rash (2 patients), and peripheral sensory neuropathy (3 patients). Thalidomide is effective in healing aphthous ulceration of the esophagus in patients infected with HIV.

Original languageEnglish (US)
Pages (from-to)61-67
Number of pages7
JournalJournal of Infectious Diseases
Volume180
Issue number1
DOIs
StatePublished - Jul 5 1999
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • Immunology and Allergy
  • Infectious Diseases

Cite this

Jacobson, J. M., Spritzler, J., Fox, L., Fahey, J. L., Jackson, J. B., Chernoff, M., Wohl, D. A., Wu, A. W., Hooton, T. M., Sha, B. E., Shikuma, C. M., MacPhail, L. A., Simpson, D. M., Trapnell, C. B., & Basgoz, N. (1999). Thalidomide for the treatment of esophageal aphthous ulcers in patients with human immunodeficiency virus infection. Journal of Infectious Diseases, 180(1), 61-67. https://doi.org/10.1086/314834